Heart Attack Response: Door-To-Balloon Times Can Be Lowered Using Process Improvement Strategies
While all heart attacks have the potential to be deadly, one type is referred to as the "widow maker" because of its high risk of death. A ST segment elevation myocardial infarction (STEMI) is a severe type of heart attack that occurs when a blockage in a coronary artery causes heart muscle to die; without prompt treatment risk of fatality increases dramatically. Coronary angioplasty, or percutaneous coronary intervention (PCI), is the most common emergency treatment for STEMI... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 1, 2013 Category: Consumer Health News Tags: Heart Disease Source Type: news
Stent Graft Maintains Dialysis Access (CME/CE)
NEW ORLEANS (MedPage Today) -- The Flair endovascular stent graft was better than balloon angioplasty at keeping hemodialysis access grafts open through 12 months, interim results of a randomized trial showed. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - April 16, 2013 Category: Journals (General) Source Type: news
Drug-Eluting Stents May Save Ischemic Limbs (CME/CE)
NEW ORLEANS (MedPage Today) -- Drug-eluting stents provide good outcomes for patients with critical limb ischemia in whom balloon angioplasty has failed, a single-center study showed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 15, 2013 Category: Cardiology Source Type: news
Drug-Eluting Balloon Angioplasty for in-Stent RestenosisDrug-Eluting Balloon Angioplasty for in-Stent Restenosis
What's the optimal treatment option for in-stent restenosis? Heart (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 4, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Changing the face of Midaortic Syndrome treatment to save Sofia
The American Journal of Transplantation recently published a paper, documenting a first-of-its-kind treatment for midaortic syndrome, as performed by Khashayar Vakili, MD, of Boston Children’s Department of Surgery and Heung Bae Kim, MD, director of Boston Children’s Pediatric Transplant Center.
In the following blog Marcus Groff, father of the patient described in the Journal of Transplantation, writes about his daughter’s revolutionary surgery at Boston Children’s.
Sofia
Two years ago my wife and I were anxiously waiting outside the NICU of our local hospital at four in the morning. Inside, our...
Source: Thrive, Children's Hospital Boston - February 25, 2013 Category: Pediatrics Authors: Guest Blogger Tags: All posts Diseases & conditions Heart conditions Our patients’ stories Heung Bae Kim kidney transplant midaortic syndrome Midaortic Syndrome and Renovascular Hypertension (MAS/RVH) Program our patients' stories Pediatric Transplant Cen Source Type: news
AngioScore Launches New 100 mm Length AngioSculpt(R) Scoring Balloons For Treatment of Peripheral Artery Disease Below The Knee (BTK)
FREMONT, Calif.--(Healthcare Sales & Marketing Network)--AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Ca... Devices, InterventionalAngioScore, AngioSculpt, Scoring Balloon Catheter, peripheral artery disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2013 Category: Pharmaceuticals Source Type: news
AngioScore Launches New 100 mm Length AngioSculpt Scoring Balloons For Treatment Of Peripheral Artery Disease Below The Knee (BTK)
AngioScore, Inc.,a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, recently announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK) (Source: Medical Design Online News)
Source: Medical Design Online News - January 25, 2013 Category: Medical Equipment Source Type: news
Medtronic Drug-Eluting Balloon Study Completes Enrollment
Medtronic, Inc. (NYSE: MDT), today announced completion of enrollment in IN.PACT SFA II, the U.S. arm of its clinical study for the IN.PACT Admiral drug-eluting balloon as a treatment for peripheral artery disease in the superficial femoral and proximal popliteal arteries (SFA and PPA). Results of IN.PACT SFA II will be combined with those from IN.PACT SFA I, which previously completed enrollment of 150 patients in Europe, to support a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA). (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 23, 2013 Category: Cardiology Source Type: news
Drug-Eluting Balloon: Best Option for in-Stent Restenosis?Drug-Eluting Balloon: Best Option for in-Stent Restenosis?
The first meta-analysis to compare drug-eluting balloons with drug-eluting stents or plain angioplasty for in-stent restenosis indicates that the balloon comes out best. Guidelines should be changed accordingly, say the researchers, but others say this conclusion is premature. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 23, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news
Drug-eluting balloon: Best option for in-stent restenosis?
The first meta-analysis to compare drug-eluting balloons with drug-eluting stents or plain angioplasty for in-stent restenosis indicates that the balloon comes out best. Guidelines should be changed accordingly, say the researchers, but others say this conclusion is premature. (Source: theHeart.org)
Source: theHeart.org - January 22, 2013 Category: Cardiology Source Type: news
